Hanson Wade

🚀 The 8th Annual RNAi-Based Therapeutics Summit is officially back for 2027! As the RNAi field enters a new era of growth, join 90+ industry leaders, innovators, and decision-makers in Boston to explore the future of extrahepatic RNAi delivery across obesity, metabolic disease, cardiovascular disease, neurology, and oncology. Featuring expert insights from organizations including Bayer, Eli Lilly and Company, Novo Nordisk, Thalia Therapeutics Plc, SanegeneBio, Aro Biotherapeutics, GenKardia, and more, the brand-new 2027 program is designed to help advance the development of safer, more potent RNAi therapeutics. 📍 Boston, MA 📅 January 27-29, 2027 Download the full event guide to explore the new agenda, expert speaker faculty, and key discussions shaping the next generation of RNAi therapeutics. 🔗 https://ter.li/cs7060nd

We’re delighted to shine another spotlight on one of our expert speakers at this year’s Amylin-Based Therapeutics Summit (December 1-3, Boston). Professor Debbie Hay, University of Otago, will take to the stage for a session discussing ‘Learning from the CGRP Field to Advance Amylin Receptor Pharmacology’. To see full session details, view the event guide: https://lnkd.in/eN68kZFG   #amylin #amylinsummit

What does it take to translate better protein designs into successful therapeutics? 🧬 Hear from the wet & dry lab experts advancing antibody engineering, AI-driven protein design, structural biology, and developability at the Protein Design & Engineering in Biopharma Summit. We have a great variety of industry leading expert companies taking to the stage, including: AbbVie, AI Proteins, Crossbow Therapeutics, Inc, CSL, Diagonal Therapeutics, Fable Therapeutics, GSK, InduPro, ModeX Therapeutics Inc, Takeda, Tectonic Therapeutic, Inc., Versatope Therapeutics, Inc., Xencor 🎤 To take a look at the speakers and their sessions in more detail, check out our full event guide here: https://ter.li/67x043ve P.S. ⏰ Our early bird savings of up to $735 end this Friday. Secure your pass today to join the industry's only dedicated forum covering the entire Design-Build-Test-Learn cycle: https://ter.li/s5aksbv2 #ProteinEngineering #ProteinDesign #AntibodyEngineering #Biophysics #BiologicsRND

🎤 New Speaker Interviews Now Live Want a sneak peek at the discussions shaping the future of microbiome therapeutics? Our latest speaker interviews are now live, featuring: ✅ Bernat Olle, CEO, Vedanta Biosciences ✅ Benjamin Hadida, Co-Founder & CEO, Exeliom Biosciences From the latest scientific breakthroughs to the next generation of microbiome-based therapies, these conversations offer exclusive insights into the topics set to define this year's 11th Annual Microbiome Movement Summit USA. 📖 Read the interviews now and discover what these industry leaders are most excited to discuss in Boston this November: https://ter.li/ajoeb3ux ⏰ Last chance to save up to $600! Early bird registration expires Friday, 25 September. Secure your place and lock in the biggest discount before rates increase. 📍 Boston, MA 📅 November 9-11, 2026 #MicrobiomeMovement #MicrobiomeTherapeutics #Biotech #LifeSciences #DrugDevelopment #MicrobiomeScience

Intranasal delivery is entering a new era. As investment accelerates across CNS, neurological, infectious disease and emergency-use therapies, developers face increasing pressure to improve bioavailability, navigate regulatory pathways, optimize drug-device compatibility, and demonstrate clinical success. That's why the 5th Nasal Formulation & Delivery Summit returns to Washington, DC on February 2-4, 2027. Join the community advancing next-generation nasal therapies and hear first-hand case studies on: ✅ Formulation development ✅ Device innovation ✅ Clinical translation ✅ CMC & regulatory strategy ✅ Commercialization planning 📖 Download the full event guide to explore the agenda, speaker faculty, and attending companies: https://ter.li/5y1wghz8 #NasalDrugDelivery #DrugDelivery #IntranasalDelivery #Pharma #Biotech #CNSDrugDelivery

Today, we are pleased to celebrate World Cancer Research Day🎗️ The latest advancements in cancer research would not be possible without the clinicians and innovators who are constantly pushing the boundaries of what we already know and working to create better outcomes for patients across the globe. As we look towards the future of cancer care, we’re proud to be uniting the precision oncology community together at the 16th World Clinical Biomarkers & Companion Diagnostics Summit, in less than 2 weeks' time.

🤝 Meet the Sponsor: GemPharmatech Joining us at the 2nd T-Cell Engager for Autoimmune Disease Summit is GemPharmatech, a global contract research organization providing genetically engineered mouse models and preclinical research services. With a library of more than 25,000 models, alongside custom model generation, breeding and compound efficacy testing, GemPharmatech supports researchers in advancing their preclinical programs. 📅 Join them at this event, taking place in just 5 weeks. 📥 Want to find out more? Download the event guide to discover who will be there and what will be discussed: https://ter.li/sq7nf410 #TCellEngagerSummit #TCellEngagers #AutoimmuneDisease #PreclinicalDevelopment #MouseModels #DrugDiscovery #Biotech #Immunology

🎤 Meet the Speaker & Chair: Jacek Ostrowski How can developers overcome the biological barriers limiting oligonucleotide delivery beyond the liver? At the Oligonucleotide-based Therapeutics Summit, Jacek Ostrowski, Senior Director, Protein Science at Avidity Biosciences, Inc., will chair the main conference and lead an interactive workshop focused on today’s leading extrahepatic delivery strategies. Through real-world case studies, attendees will compare emerging targeting platforms, examine where approaches have succeeded or broken down, and build a practical framework for selecting the right delivery strategy for their programs. 📥 Download the brochure to dive deeper into Jacek’s session and explore the full industry-leading agenda: https://ter.li/8md8nlfv #OligonucleotideBasedTherapeutics #ExtrahepaticDelivery #Oligonucleotides #DrugDevelopment #RNAtherapeutics #Biopharma #CNSDelivery #MeetTheSpeaker

𝟭𝟬𝘁𝗵 𝗗𝗲𝗿𝗺𝗮𝘁𝗼𝗹𝗼𝗴𝘆 𝗗𝗿𝘂𝗴 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗦𝘂𝗺𝗺𝗶𝘁 Greater Indication Diversity & Double The Content   In case you didn't know, the 10th Dermatology Drug Development Summit is expanding both the breadth of indications covered and the depth of scientific discussion available to attendees.   In just 6 weeks' time, we will be joined by industry-leading companies at our 10th Anniversary, including: Alphyn Biologics, Inc., Merck & Co, AOBiome Therapeutics, Inc. Alnivo Therapeutics, AbbVie, Eli Lilly and Company, Galderma, Azitra Inc, SUN PHARMA, Navigator Medicines, Inc., Mariposa Therapeutics, Enveda, Nogra Pharma, UNION therapeutics A/S, KALM Therapeutics. With just weeks to go, now is the time to compare your pipeline against the wider dermatology field, learn what is translating into clinical practice, and shape your R&D strategy for 2027.   Find out more about our meeting and key sessions not to be missed: https://ter.li/mi29glaq

Meet senior leaders from Roche, Philips, Straumann, Huma, Aiforia Technologies, Edwards Lifesciences, Elekta, Medicines and Healthcare products Regulatory Agency, FIRE1, Medbase Gruppe and more as they share how they are advancing software-enabled medical devices through AI, digital health, quality, regulatory excellence, and product innovation. Whether you're focused on software development, SaMD, cybersecurity, AI integration, quality management, or regulatory strategy, this is your opportunity to connect with the organisations shaping the future of MedTech. Join 100+ software, regulatory, quality, R&D, engineering, and digital health leaders at the 4th Annual Medical Device Software Development Summit Europe. 📅 8-10 December 2026 | Munich, Germany 👉 Download the brochure: https://ter.li/nld6ihxm #MedicalDeviceSoftware #MedTech #SaMD #DigitalHealth #MedicalDevices #SoftwareDevelopment #AIInHealthcare #RegulatoryAffairs #QualityAssurance #MedTechEurope